Skip to main content
Premium Trial:

Request an Annual Quote

Deepcell, University of Zurich Partner to Study Melanoma Microenvironment

NEW YORK – Deepcell said Tuesday that it is collaborating with the University of Zurich's Levesque Lab in a study of the tumor microenvironment in melanomas.

Researchers will use Deepcell's rare cell isolation and analysis platform, which allows cells to be isolated based on morphological features rather than labeling or predefined biomarkers, to sort cells for downstream molecular analysis.

"Melanoma cells are difficult to isolate with conventional sorting methods because they lack reliable cell surface markers. By isolating and sorting cells using morphology, we may deepen our understanding of the biology of melanoma progression and, in particular, of cell phenotypes and molecular features of cancerous cells," Mitch Levesque, associate professor at the University of Zurich, said in a statement.

Financial terms were not disclosed.

Deepcell has said that it intends to build a broad academic partnership program and inked a similar research collaboration with investigators at the University of California, Los Angeles earlier this year.

The Scan

University of Michigan President Fired

Mark Schlissel, the president of the University of Michigan, has been fired after an investigation into allegations he had an affair with a subordinate, the Washington Post reports.

Recommendation to Drop Charges

The Wall Street Journal says federal prosecutors recommended charges against MIT's Gang Chen, who was caught up by the China Initiative, be dropped.

Mix 'Em Together

The Guardian reports Moderna is planning to have a combination SARS-CoV-2, influenza, and RSV vaccine by the 2023 flu season.

PNAS Papers on Earth BioGenome Project, SETX Knockouts, Pig Model of Cystic Fibrosis

In PNAS this week: Earth BioGenome Project reports progress, analysis of cells missing the progressive neurodegenerative disease-linked SETX gene, and more.